$17.4 Billion is the total value of VIKING GLOBAL INVESTORS LP's 57 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EIDX | EIDOS THERAPEUTICS INC | $46,576,000 | +70.4% | 1,986,201 | 0.0% | 0.27% | +71.2% | |
| EDIT | EDITAS MEDICINE INC | $22,773,000 | +7.5% | 931,401 | 0.0% | 0.13% | +8.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 38 | Q1 2024 | 7.0% |
| AMAZON COM INC | 37 | Q2 2024 | 10.6% |
| META PLATFORMS INC | 37 | Q2 2024 | 10.4% |
| MICROSOFT CORP | 32 | Q2 2024 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 31 | Q1 2024 | 5.4% |
| NETFLIX INC | 27 | Q2 2024 | 6.0% |
| MASTERCARD INCORPORATED | 27 | Q1 2024 | 3.9% |
| UNITEDHEALTH GROUP INC | 25 | Q2 2024 | 5.3% |
| BIOMARIN PHARMACEUTICAL INC | 25 | Q2 2024 | 2.7% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| APi Group Corp | June 18, 2024 | 27,032,516 | 9.9% |
| Inhibrx Biosciences, Inc. | June 07, 2024 | 1,787,705 | 12.3% |
| Inhibrx, Inc.Sold out | June 03, 2024 | 0 | 0.0% |
| STANDARD BIOTOOLS INC. | March 20, 2024 | 58,651,170 | 15.3% |
| RayzeBio, Inc.Sold out | February 28, 2024 | 0 | 0.0% |
| Adaptive Biotechnologies Corp | February 14, 2024 | 29,993,708 | 20.7% |
| Amylyx Pharmaceuticals, Inc. | February 14, 2024 | 2,962,555 | 4.4% |
| Edgewise Therapeutics, Inc. | February 14, 2024 | 6,159,146 | 9.7% |
| Five9, Inc. | February 14, 2024 | 2,714,117 | 3.7% |
| Ginkgo Bioworks Holdings, Inc. | February 14, 2024 | 143,085,126 | 8.8% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-03 |
| SC 13D/A | 2024-08-20 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-15 |
| 4 | 2024-06-18 |
| 4 | 2024-06-18 |
| SC 13G/A | 2024-06-18 |
| 3 | 2024-06-07 |
| SC 13G | 2024-06-07 |
| 4 | 2024-06-03 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.